Search

Ignacio M Aliagas

from San Francisco, CA
Age ~61

Ignacio Aliagas Phones & Addresses

  • 345 Princeton St, San Francisco, CA 94134 (415) 452-8901
  • 140 Van Ness Ave, San Francisco, CA 94103 (415) 503-1996
  • Las Vegas, NV
  • Sausalito, CA
  • San Rafael, CA
  • Menlo Park, CA

Work

Company: Genentech Position: Sra

Education

School / High School: San Francisco State University 1993 to 1996

Emails

i***s@excite.com

Industries

Biotechnology

Resumes

Resumes

Ignacio Aliagas Photo 1

Pra At Genentech

View page
Position:
SRA at Genentech
Location:
San Francisco Bay Area
Industry:
Biotechnology
Work:
Genentech
SRA
Education:
San Francisco State University 1993 - 1996
Universidad de Valladolid 1984 - 1987
Universidad de Valladolid 1979 - 1983

Publications

Us Patents

Raf Inhibitor Compounds And Methods Of Use Thereof

View page
US Patent:
2012021, Aug 23, 2012
Filed:
Aug 27, 2010
Appl. No.:
13/393138
Inventors:
Ignacio Aliagas - South San Francisco CA,
Stefan Gradl - South San Francisco CA,
Janet Gunzner - South San Francisco CA,
Simon Mathieu - South San Francisco CA,
Rebecca Pulk - South San Francisco CA,
Joachim Rudolph - South San Francisco CA,
Zhaoyang Wen - South San Francisco CA,
International Classification:
A61K 31/5377
A61K 31/505
A61P 35/00
C07D 403/12
C07D 251/42
A61K 31/53
C07D 239/48
C07D 413/12
US Classification:
5142358, 544329, 514256, 544122, 544328, 544211, 514245
Abstract:
Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers, tautomers, prodrugs and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

Raf Inhibitor Compounds And Methods Of Use Thereof

View page
US Patent:
2013001, Jan 17, 2013
Filed:
Aug 27, 2010
Appl. No.:
13/393116
Inventors:
Ignacio Aliagas - South San Francisco CA,
Stefan Gradl - South San Francisco CA,
Janet Gunzner - South San Francisco CA,
Wendy Lee - South San Francisco CA,
Simon Mathieu - South San Francisco CA,
Joachim Rudolph - South San Francisco CA,
Zhaoyang Wen - South San Francisco CA,
Guiling Zhao - South San Francisco CA,
Alexandre J. Buckmelter - Boulder CO,
Jonas Grina - Boulder CO,
Joshua D. Hansen - Boulder CO,
Ellen Laird - Boulder CO,
David Moreno - Boulder CO,
Li Ren - Boulder CO,
Steven Mark Wenglowsky - Boulder CO,
Assignee:
ARRAY BIOPHARMA INC. - Boulder CO
International Classification:
A61K 31/517
C07D 471/04
A61K 31/519
C07D 405/12
A61P 35/02
C07D 401/12
C07D 413/12
A61K 31/5377
C07D 239/72
A61P 35/00
C07D 239/94
C07D 403/12
US Classification:
51421021, 544293, 5142664, 544279, 51426411, 544119, 5142345, 544284, 544283, 5142661
Abstract:
Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers, tautomers, prodrugs and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

Raf Inhibitor Compounds And Methods Of Use Thereof

View page
US Patent:
2012015, Jun 21, 2012
Filed:
Aug 27, 2010
Appl. No.:
13/393163
Inventors:
Ignacio Aliagas - South San Francisco CA,
Stefan Gradl - South San Francisco CA,
Janet Gunzner - South San Francisco CA,
Simon Mathieu - South San Francisco CA,
Rebecca Pulk - South San Francisco CA,
Joachim Rudolph - South San Francisco CA,
Zhaoyang Wen - South San Francisco CA,
Jonas Grina - Boulder CO,
Joshua D. Hansen - Boulder CO,
Ellen Laird - Boulder CO,
David Moreno - Boulder CO,
Li Ren - Boulder CO,
Steven Mark Wenglowsky - Boulder CO,
Assignee:
GENENTECH, INC. - South San Francisco CA
ARRAY BIOPHARMA INC. - Boulder CO
International Classification:
A61K 31/519
C07D 495/04
A61P 35/00
A61K 31/5377
A61K 31/53
C07D 487/04
C07D 513/04
US Classification:
51421021, 544280, 544278, 544255, 544117, 544183, 5142651, 5142601, 5142342, 514243
Abstract:
Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers, tautomers, prodrugs and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

Raf Inhibitor Compounds And Methods Of Use Thereof

View page
US Patent:
2012015, Jun 21, 2012
Filed:
Aug 27, 2010
Appl. No.:
13/393111
Inventors:
Ignacio Aliagas - South San Francisco CA,
Stefan Gradl - South San Francisco CA,
Janet Gunzner - South San Francisco CA,
Simon Mathieu - South San Francisco CA,
Joachim Rudolph - South San Francisco CA,
Zhaoyang Wen - South San Francisco CA,
Steven Mark Wenglowsky - Boulder CO,
Assignee:
GENENTECH, INC. - South San Francisco CA
ARRAY BIOPHARMA INC. - Boulder CO
International Classification:
A61K 31/519
A61K 31/52
C07D 487/04
C07D 495/04
C07D 491/048
A61P 13/12
A61P 35/00
A61P 25/28
A61P 9/00
A61P 29/00
A61P 25/06
A61P 25/00
C07D 473/34
A61K 31/5377
US Classification:
5142342, 544277, 5142634, 544262, 5142621, 544280, 5142651, 544254, 5142611, 544278, 5142601, 544250, 514267, 51426337, 544118
Abstract:
Compounds of Formula II are useful for inhibition of Raf kinases. Methods of using compounds of Formula II and stereoisomers, tautomers, prodrugs and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
Ignacio M Aliagas from San Francisco, CA, age ~61 Get Report